C(h)AR-ting a new course in incurable lymphomas: CAR T cells for mantle cell and follicular lymphomas

被引：13
|
作者：
Jacobson, Caron A. [1 ]
Maus, Marcela, V [2 ]
机构：
[1] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
BLOOD ADVANCES | 2020年 / 4卷 / 22期
关键词：
INHIBITOR IBRUTINIB; MALIGNANCIES; POPULATION; EFFICACY; OUTCOMES; BTK;
D O I：
10.1182/bloodadvances.2020003391
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chimeric antigen receptor (CAR) T-cell therapy targeting CD19 has transformed the natural history of relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell non-Hodgkin lymphoma. Based on these results, CD19 CAR T cells have since been tested in largely incurable lymphomas, including mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma, with promising early results that raise the question of whether this cellular immunotherapy could have curative potential and change the natural history of these diseases. This article reviews these results and this hypothesis.
引用
收藏
页码：5858 / 5862
页数：5
相关论文
共 50 条
  • [41] Polytypic B-Cells, B-Cell Lymphoproliferative Disorders/Lymphomas, and Neoplastic T-Cells Divergently Differentiate from TET2-/ DNMT3A-Mutated Clonal Hematopoiesis in Patients with Follicular Helper T-Cell Lymphomas/Lymphoproliferative Disorders
    Lewis, Natasha
    Petrova-Drus, Kseniya
    Sardana, Rohan
    Gao, Qi
    Sethi, Shenon
    Xiao, Wenbin
    Roshal, Mikhail
    Baik, Jeeyeon
    Bhurtel, Himanshu
    Moskowitz, Alison
    Horwitz, Steven M.
    Dogan, Ahmet
    BLOOD, 2023, 142
  • [42] CAR-T-Cell Therapy for Patients with relapsed or refractory aggressive B-Cell-Lymphomas New Data prove Long-term Effectiveness
    Arnheim, Katharina
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 (04) : 204 - 207
  • [43] RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells
    Vallois, David
    Dupuy, Aurelie
    Lemonnier, Francois
    Allen, George
    Missiaglia, Edoardo
    Fataccioli, Virginie
    Ortonne, Nicolas
    Clavert, Aline
    Delarue, Richard
    Rousselet, Marie-Christine
    Fabiani, Bettina
    Llamas-Gutierrez, Francisco
    Ogawa, Seishi
    Thome, Margot
    Ko, Young Hyeh
    Kataoka, Keisuke
    Gaulard, Philippe
    de Leval, Laurence
    HAEMATOLOGICA, 2018, 103 (08) : E360 - E363
  • [44] EVALUATION OF TENASCIN-C BY TENATUMOMAB IN T-CELL NON-HODGKIN LYMPHOMAS IDENTIFIES A NEW TARGET FOR RADIOIMMUNOTHERAPY
    Gritti, G.
    Gianatti, A.
    Petronzelli, F.
    De Santis, R.
    Pavoni, C.
    Rossi, R. L.
    Cattaneo, L.
    Spagnoli, L. G.
    Ferrari, S.
    Rossi, A.
    Barbui, A. M.
    Rambaldi, A.
    HAEMATOLOGICA, 2017, 102 : 36 - 36
  • [45] Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical Hyperplasia A Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin
    Abukhiran, Ibrahim
    Syrbu, Sergei, I
    Holman, Carol J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (03) : 409 - 426
  • [46] A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
    Yang Wu
    Dan Chen
    Ya Lu
    Shu-Chen Dong
    Rong Ma
    Wei-yan Tang
    Jian-qiu Wu
    Ji-Feng Feng
    Jian-Zhong Wu
    Cancer Gene Therapy, 2022, 29 : 167 - 177
  • [47] A new immunotherapy strategy targeted CD30 in peripheral T-cell lymphomas: CAR-modified T-cell therapy based on CD30 mAb
    Wu, Yang
    Chen, Dan
    Lu, Ya
    Dong, Shu-Chen
    Ma, Rong
    Tang, Wei-yan
    Wu, Jian-qiu
    Feng, Ji-Feng
    Wu, Jian-Zhong
    CANCER GENE THERAPY, 2022, 29 (02) : 167 - 177
  • [48] LEUKEMIC NON-HODGKINS-LYMPHOMAS WITH HYPERDIPLOID CELLS AND T(11-14)(Q13-Q32) - A SUBTYPE OF MANTLE CELL LYMPHOMA
    DANIEL, MT
    TIGAUD, I
    FLEXOR, MA
    NOGUEIRA, ME
    BERGER, R
    JONVEAUX, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (01) : 77 - 84
  • [49] LYMPHOMAS IN C3H MICE PERINATALLY INOCULATED WITH (C3H BY T6) F1 OR C3H SPLEEN-CELLS
    HARD, RC
    CROSS, SS
    EUROPEAN JOURNAL OF CANCER, 1980, 16 (06) : 817 - 831
  • [50] Patients Outcome after Chimeric Antigen Receptor (CAR) T-Cells Failure in Aggressive B-Cell Lymphomas: Role of Immunotherapy and Prognostic Factors
    Dodero, Anna
    Bramanti, Stefania
    Pennisi, Martina
    Ljevar, Silva
    Chiappella, Annalisa
    Magagnoli, Massimo
    Guidetti, Anna
    Corrado, Francesco
    Nierychlewska, Paulina
    Di Rocco, Alice
    Cabras, Antonello Domenico
    Rahal, Daoud
    De Philippis, Chiara
    Santoro, Armando
    Carlo-Stella, Carmelo
    Corradini, Paolo
    BLOOD, 2022, 140 : 9468 - 9469
12345